Effects of vitamin C, vitamin E, zinc gluconate, and selenomethionine supplementation on muscle function and oxidative stress biomarkers in patients with facioscapulohumeral dystrophy: a double-blind randomized controlled clinical trial.
[en] Facioscapulohumeral muscular dystrophy (FSHD) is an autosomal dominant disease characterized by progressive weakness and atrophy of specific skeletal muscles. As growing evidence suggests that oxidative stress may contribute to FSHD pathology, antioxidants that might modulate or delay oxidative insults could help in maintaining FSHD muscle function. Our primary objective was to test whether oral administration of vitamin C, vitamin E, zinc gluconate, and selenomethionine could improve the physical performance of patients with FSHD. Adult patients with FSHD (n=53) were enrolled at Montpellier University Hospital (France) in a randomized, double-blind, placebo-controlled pilot clinical trial. Patients were randomly assigned to receive 500 mg vitamin C, 400mg vitamin E, 25mg zinc gluconate and 200 mug selenomethionine (n=26), or matching placebo (n=27) once a day for 17 weeks. Primary outcomes were changes in the two-minute walking test (2-MWT), maximal voluntary contraction, and endurance limit time of the dominant and nondominant quadriceps (MVCQD, MVCQND, TlimQD, and TlimQND, respectively) after 17 weeks of treatment. Secondary outcomes were changes in the antioxidant status and oxidative stress markers. Although 2-MWT, MVCQ, and TlimQ were all significantly improved in the supplemented group at the end of the treatment compared to baseline, only MVCQ and TlimQ variations were significantly different between groups (MVCQD: P=0.011; MVCQND: P=0.004; TlimQD: P=0.028; TlimQND: P=0.011). Similarly, the vitamin C (P<0.001), vitamin E as alpha-tocopherol (P<0.001), vitamin C/vitamin E ratio (P=0.017), vitamin E gamma/alpha ratio (P=0.022) and lipid peroxides (P<0.001) variations were significantly different between groups. In conclusion, vitamin E, vitamin C, zinc, and selenium supplementation has no significant effect on the 2-MWT, but improves MVCQ and TlimQ of both quadriceps by enhancing the antioxidant defenses and reducing oxidative stress. This trial was registered at clinicaltrials.gov (number: NCT01596803).
Disciplines :
Chirurgie
Auteur, co-auteur :
Passerieux, Emilie
Hayot, Maurice
Jaussent, Audrey
Carnac, Gilles
Gouzi, Fares
Pillard, Fabien
Picot, Marie-Christine
Bocker, Koen
Hugon, Gerald
PINCEMAIL, Joël ; Centre Hospitalier Universitaire de Liège - CHU > Chirurgie cardio-vasculaire
Defraigne, Jean-Olivier ; Université de Liège > Département des sciences cliniques > Chirurgie cardio-vasculaire et thoracique
Effects of vitamin C, vitamin E, zinc gluconate, and selenomethionine supplementation on muscle function and oxidative stress biomarkers in patients with facioscapulohumeral dystrophy: a double-blind randomized controlled clinical trial.
Date de publication/diffusion :
2015
Titre du périodique :
Free Radical Biology and Medicine
ISSN :
0891-5849
eISSN :
1873-4596
Maison d'édition :
Elsevier, Amsterdam, Pays-Bas
Volume/Tome :
81
Pagination :
158-69
Peer reviewed :
Peer reviewed vérifié par ORBi
Commentaire :
Copyright (c) 2014 Elsevier Inc. All rights reserved.
S. Pandya, W.M. King, and R. Tawil Facioscapulohumeral dystrophy Phys. Ther. 88 2008 105 113
R. Tawil, and S.M. Van Der Maarel Facioscapulohumeral muscular dystrophy Muscle Nerve 34 2006 1 15
D.B. Olsen, P. Gideon, T.D. Jeppesen, and J. Vissing Leg muscle involvement in facioscapulohumeral muscular dystrophy assessed by MRI J. Neurol. 253 2006 1437 1441
M. Richards, F. Coppee, N. Thomas, A. Belayew, and M. Upadhyaya Facioscapulohumeral muscular dystrophy (FSHD): an enigma unravelled? Hum. Genet. 131 2012 325 340
J.C. van Deutekom, C. Wijmenga, E.A. van Tienhoven, A.M. Gruter, J.E. Hewitt, G.W. Padberg, G.J. van Ommen, M.H. Hofker, and R.R. Frants FSHD associated DNA rearrangements are due to deletions of integral copies of a 3.2 kb tandemly repeated unit Hum. Mol. Genet 2 1993 2037 2042
J. Gabriels, M.C. Beckers, H. Ding, A. De Vriese, S. Plaisance, S.M. van der Maarel, G.W. Padberg, R.R. Frants, J.E. Hewitt, D. Collen, and A. Belayew Nucleotide sequence of the partially deleted D4Z4 locus in a patient with FSHD identifies a putative gene within each 3.3 kb element Gene 236 1999 25 32
J.E. Hewitt, R. Lyle, L.N. Clark, E.M. Valleley, T.J. Wright, C. Wijmenga, J.C. van Deutekom, F. Francis, P.T. Sharpe, and M. Hofker Analysis of the tandem repeat locus D4Z4 associated with facioscapulohumeral muscular dystrophy Hum. Mol. Genet 3 1994 1287 1295
D. Bosnakovski, Z. Xu, E.J. Gang, C.L. Galindo, M. Liu, T. Simsek, H.R. Garner, S. Agha-Mohammadi, A. Tassin, F. Coppee, A. Belayew, R.R. Perlingeiro, and M. Kyba An isogenetic myoblast expression screen identifies DUX4-mediated FSHD-associated molecular pathologies EMBO J. 27 2008 2766 2779
L.M. Wallace, S.E. Garwick, W. Mei, A. Belayew, F. Coppee, K.J. Ladner, D. Guttridge, J. Yang, and S.Q. Harper DUX4, a candidate gene for facioscapulohumeral muscular dystrophy, causes p53-dependent myopathy in vivo Ann Neurol. 2010
C. Vanderplanck, E. Ansseau, S. Charron, N. Stricwant, A. Tassin, D. Laoudj-Chenivesse, S.D. Wilton, F. Coppee, and A. Belayew The FSHD atrophic myotube phenotype is caused by DUX4 expression PLoS One 6 2011 e26820
V. Sharma, N. Harafuji, A. Belayew, and Y.W. Chen DUX4 differentially regulates transcriptomes of human rhabdomyosarcoma and mouse C2C12 cells PLoS One 8 2013 e64691
L.N. Geng, Z. Yao, L. Snider, A.P. Fong, J.N. Cech, J.M. Young, S.M. van der Maarel, W.L. Ruzzo, R.C. Gentleman, R. Tawil, and S.J. Tapscott DUX4 activates germline genes, retroelements, and immune mediators: implications for facioscapulohumeral dystrophy Dev Cell 22 2012 38 51
R.J. Lemmers, P.J. van der Vliet, R. Klooster, S. Sacconi, P. Camano, J.G. Dauwerse, L. Snider, K.R. Straasheijm, G.J. van Ommen, G.W. Padberg, D.G. Miller, S.J. Tapscott, R. Tawil, R.R. Frants, and S.M. van der Maarel A unifying genetic model for facioscapulohumeral muscular dystrophy Science 329 2010 1650 1653
S. Sacconi, R.J. Lemmers, J. Balog, P.J. van der Vliet, P. Lahaut, M.P. van Nieuwenhuizen, K.R. Straasheijm, R.D. Debipersad, M. Vos-Versteeg, L. Salviati, A. Casarin, E. Pegoraro, R. Tawil, E. Bakker, S.J. Tapscott, C. Desnuelle, and S.M. van der Maarel The FSHD2 gene SMCHD1 is a modifier of disease severity in families affected by FSHD1 Am. J. Hum. Genet. 2013
S.T. Winokur, Y.W. Chen, P.S. Masny, J.H. Martin, J.T. Ehmsen, S.J. Tapscott, S.M. van der Maarel, Y. Hayashi, and K.M. Flanigan Expression profiling of FSHD muscle supports a defect in specific stages of myogenic differentiation Hum. Mol. Genet 12 2003 2895 2907
R.J. Osborne, S. Welle, S.L. Venance, C.A. Thornton, and R. Tawil Expression profile of FSHD supports a link between retinal vasculopathy and muscular dystrophy Neurology 68 2007 569 577
S. Cheli, S. Francois, B. Bodega, F. Ferrari, E. Tenedini, E. Roncaglia, S. Ferrari, E. Ginelli, and R. Meneveri Expression profiling of FSHD-1 and FSHD-2 cells during myogenic differentiation evidences common and distinctive gene dysregulation patterns PLoS One 6 2011 e20966
S.T. Winokur, K. Barrett, J.H. Martin, J.R. Forrester, M. Simon, R. Tawil, S.A. Chung, P.S. Masny, and D.A. Figlewicz Facioscapulohumeral muscular dystrophy (FSHD) myoblasts demonstrate increased susceptibility to oxidative stress Neuromuscul. Disord 13 2003 322 333
M. Barro, G. Carnac, S. Flavier, J. Mercier, Y. Vassetzky, and D. Laoudj-Chenivesse Myoblasts from affected and non-affected FSHD muscles exhibit morphological differentiation defects J. Cell. Mol. Med. 14 2010 275 289
A. Turki, M. Hayot, G. Carnac, F. Pillard, E. Passerieux, S. Bommart, E. Raynaud de Mauverger, G. Hugon, J. Pincemail, S. Pietri, K. Lambert, A. Belayew, Y. Vassetzky, R. Juntas Morales, J. Mercier, and D. Laoudj-Chenivesse Functional muscle impairment in facioscapulohumeral muscular dystrophy is correlated with oxidative stress and mitochondrial dysfunction Free Radic. Biol. Med. 53 2012 1068 1079
Y.Z. Fang, S. Yang, and G. Wu Free radicals, antioxidants, and nutrition Nutrition 18 2002 872 879
R.J. Hillstrom, A.K. Yacapin-Ammons, and S.M. Lynch Vitamin C inhibits lipid oxidation in human HDL J. Nutr. 133 2003 3047 3051
J.A. Awad, J.D. Morrow, K.E. Hill, L.J. Roberts 2nd, and R.F. Burk Detection and localization of lipid peroxidation in selenium- and vitamin E-deficient rats using F2-isoprostanes J. Nutr. 124 1994 810 816
E. Niki Antioxidants in relation to lipid peroxidation Chem. Phys. Lipids 44 1987 227 253
A. Rigotti Absorption, transport, and tissue delivery of vitamin E Mol. Aspects Med. 28 2007 423 436
A.S. Prasad, J.T. Fitzgerald, J.W. Hess, J. Kaplan, F. Pelen, and M. Dardenne Zinc deficiency in elderly patients Nutrition 9 1993 218 224
L.E. Hansson, O. Nyren, R. Bergstrom, A. Wolk, A. Lindgren, J. Baron, and H.O. Adami Nutrients and gastric cancer risk. A population-based case-control study in Sweden Int. J. Cancer 57 1994 638 644
S.D. Mark, Y.L. Qiao, S.M. Dawsey, Y.P. Wu, H. Katki, E.W. Gunter, J.F. Fraumeni Jr, W.J. Blot, Z.W. Dong, and P.R. Taylor Prospective study of serum selenium levels and incident esophageal and gastric cancers J. Natl. Cancer Inst. 92 2000 1753 1763
Y. Xia, K.E. Hill, D.W. Byrne, J. Xu, and R.F. Burk Effectiveness of selenium supplements in a low-selenium area of China Am. J. Clin. Nutr. 81 2005 829 834
K.H. Brown, J.A. Rivera, Z. Bhutta, R.S. Gibson, J.C. King, B. Lonnerdal, M.T. Ruel, B. Sandtrom, E. Wasantwisut, C. Hotz International Zinc Nutrition Consultative Group (IZiNCG) technical document #1 Assessment of the risk of zinc deficiency in populations and options for its control Food Nutr. Bull 25 2004 S99 203
E.R. Monsen Dietary reference intakes for the antioxidant nutrients: vitamin C, vitamin E, selenium, and carotenoids J. Am. Diet. Assoc. 100 2000 637 640
P. Trumbo, A.A. Yates, S. Schlicker, and M. Poos Dietary reference intakes: vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc J. Am. Diet. Assoc. 101 2001 294 301
D. Brooks, J. Parsons, J.P. Hunter, M. Devlin, and J. Walker The 2-minute walk test as a measure of functional improvement in persons with lower limb amputation Arch. Phys. Med. Rehabil. 82 2001 1478 1483
A.S. Leung, K.K. Chan, K. Sykes, and K.S. Chan Reliability, validity, and responsiveness of a 2-min walk test to assess exercise capacity of COPD patients Chest 130 2006 119 125
C. Koechlin, A. Couillard, D. Simar, J.P. Cristol, H. Bellet, M. Hayot, and C. Prefaut Does oxidative stress alter quadriceps endurance in chronic obstructive pulmonary disease? Am. J. Respir. Crit Care Med. 169 2004 1022 1027
K. Shimoi, H. Kasai, N. Yokota, S. Toyokuni, and N. Kinae Comparison between high-performance liquid chromatography and enzyme-linked immunosorbent assay for the determination of 8-hydroxy-2′-deoxyguanosine in human urine Cancer Epidemiol. Biomarkers Prev 11 2002 767 770
P.W. Lunt, and P.S. Harper Genetic counselling in facioscapulohumeral muscular dystrophy J. Med. Genet. 28 1991 655 664
J. Haleng, J. Pincemail, J.O. Defraigne, C. Charlier, and J.P. Chapelle [Oxidative stress] Rev. Med. Liege 62 2007 628 638
J. Pincemail, C. Le Goff, C. Charlier, P. Gillion, J.P. Cheramy-Bien, E. Van Honacker, J.P. Chapelle, and J.O. Defraigne Evaluation biologique du stress oxydant: application en routine clinique Nutr. Endocrinol 2009 16 31
J. Pincemail, S. Vanbelle, U. Gaspard, G. Collette, J. Haleng, J.P. Cheramy-Bien, C. Charlier, J.P. Chapelle, D. Giet, A. Albert, R. Limet, and J.O. Defraigne Effect of different contraceptive methods on the oxidative stress status in women aged 40 48 years from the ELAN study in the province of Liege, Belgium Hum. Reprod. 22 2007 2335 2343
D.I. Thurnham, J.A. Davies, B.J. Crump, R.D. Situnayake, and M. Davis The use of different lipids to express serum tocopherol: lipid ratios for the measurement of vitamin E status Ann. Clin. Biochem. 23 Pt 5 1986 514 520
H. Baker, G.J. Handelman, S. Short, L.J. Machlin, H.N. Bhagavan, E.A. Dratz, and O. Frank Comparison of plasma alpha and gamma tocopherol levels following chronic oral administration of either all-rac-alpha-tocopheryl acetate or RRR-alpha-tocopheryl acetate in normal adult male subjects Am. J. Clin. Nutr. 43 1986 382 387
B. Halliwell Reactive oxygen species and the central nervous system J. Neurochem. 59 1992 1609 1623
M.B. Yim, P.B. Chock, and E.R. Stadtman Enzyme function of copper, zinc superoxide dismutase as a free radical generator J. Biol. Chem. 268 1993 4099 4105
B.A. Omar, and J.M. McCord The cardioprotective effect of Mn-superoxide dismutase is lost at high doses in the postischemic isolated rabbit heart Free Radic. Biol. Med. 9 1990 473 478
V.I. Lushchak Glutathione homeostasis and functions: potential targets for medical interventions J. Amino Acids 2012 2012 736837
I. Nemeth, and D. Boda The ratio of oxidized/reduced glutathione as an index of oxidative stress in various experimental models of shock syndrome Biomed. Biochim. Acta 48 1989 S53 57
S.A. Wohaieb, and D.V. Godin Alterations in free radical tissue-defense mechanisms in streptozocin-induced diabetes in rat. Effects of insulin treatment Diabetes 36 1987 1014 1018
E. Niki, A. Kawakami, Y. Yamamoto, and Y. Kamiya Synergistic inhibition of oxidation of phosphatidycholine liposomes in aqueous dispersion by vitamin E and vitamin C Bull. Chem. Soc. Jpn. 58 1985 1971 1975
E. Niki, Y. Tsuchiya, R. Tanimura, and Y. Kamiya Regeneration of vitamin E from α-chromanoxy radical by glutathione and vitamin C Chem. Lett. 1982 789 792
S. Li, T. Yan, J.Q. Yang, T.D. Oberley, and L.W. Oberley The role of cellular glutathione peroxidase redox regulation in the suppression of tumor cell growth by manganese superoxide dismutase Cancer Res. 60 2000 3927 3939
J.D. Morrow, Y. Chen, C.J. Brame, J. Yang, S.C. Sanchez, J. Xu, W.E. Zackert, J.A. Awad, and L.J. Roberts The isoprostanes: unique prostaglandin-like products of free-radical-initiated lipid peroxidation Drug Metab. Rev. 31 1999 117 139
J.D. Morrow, B. Frei, A.W. Longmire, J.M. Gaziano, S.M. Lynch, Y. Shyr, W.E. Strauss, J.A. Oates, and L.J. Roberts 2nd Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage N. Engl. J. Med. 332 1995 1198 1203
A. Barden, L.J. Beilin, J. Ritchie, K.D. Croft, B.N. Walters, and C.A. Michael Plasma and urinary 8-iso-prostane as an indicator of lipid peroxidation in pre-eclampsia and normal pregnancy Clin. Sci. (Lond.) 91 1996 711 718
D. Tsikas, M.T. Suchy, J. Niemann, P. Tossios, Y. Schneider, S. Rothmann, F.M. Gutzki, J.C. Frolich, and D.O. Stichtenoth Glutathione promotes prostaglandin H synthase (cyclooxygenase)-dependent formation of malondialdehyde and 15(S)-8-iso-prostaglandin F2alpha FEBS Lett. 586 2012 3723 3730
R.J. Wood Assessment of marginal zinc status in humans J. Nutr. 130 2000 1350S 1354S
P.M. Filipe, A.C. Fernandes, and C.F. Manso Effects of zinc on copper-induced and spontaneous lipid peroxidation Biol. Trace Elem. Res. 47 1995 51 56
A. Carr, and B. Frei Does vitamin C act as a pro-oxidant under physiological conditions? FASEB J 13 1999 1007 1024
R.A. Sunde Selenium B.A. Bowman, R.M. Russel, Present knowledge in nutrition 2006 ILSI Press, Washington, DC Washington 480 497
D.L. Hatfield, M.J. Berry, and V.N. Gladyshev Selenium. Its molecular biology and role in human health 2nd ed. 2006 Springer New York
B. Celegato, D. Capitanio, M. Pescatori, C. Romualdi, B. Pacchioni, S. Cagnin, A. Vigano, L. Colantoni, S. Begum, E. Ricci, R. Wait, G. Lanfranchi, and C. Gelfi Parallel protein and transcript profiles of FSHD patient muscles correlate to the D4Z4 arrangement and reveal a common impairment of slow to fast fibre differentiation and a general deregulation of MyoD-dependent genes Proteomics 6 2006 5303 5321
D. Laoudj-Chenivesse, G. Carnac, C. Bisbal, G. Hugon, S. Bouillot, C. Desnuelle, Y. Vassetzky, and A. Fernandez Increased levels of adenine nucleotide translocator 1 protein and response to oxidative stress are early events in facioscapulohumeral muscular dystrophy muscle J. Mol. Med. 83 2005 216 224
V. Macaione, M. Aguennouz, C. Rodolico, A. Mazzeo, A. Patti, E. Cannistraci, L. Colantone, R.M. Di Giorgio, G. De Luca, and G. Vita RAGE-NF-kappaB pathway activation in response to oxidative stress in facioscapulohumeral muscular dystrophy Acta Neurol. Scand. 115 2007 115 121
D. Bosnakovski, S.H. Choi, J.M. Strasser, E.A. Toso, M.A. Walters, and M. Kyba High-throughput screening identifies inhibitors of DUX4-induced myoblast toxicity Skelet. Muscle 4 2014 4
S. Netelson Microtechniques of clinical chemistry for the routine laboratory 1957 Springfield Illinois 381
M. Raes, C. Michiels, and J. Remacle Comparative study of the enzymatic defense systems against oxygen-derived free radicals: the key role of glutathione peroxidase Free Radic. Biol. Med. 3 1987 3 7
R.A. DiSilvestro, J. Selsby, and K. Siefker A pilot study of copper supplementation effects on plasma F2alpha isoprostanes and urinary collagen crosslinks in young adult women J. Trace Elem. Med. Biol. 24 2010 165 168
D. Ozcelik, R. Ozaras, Z. Gurel, H. Uzun, and S. Aydin Copper-mediated oxidative stress in rat liver Biol. Trace Elem. Res. 96 2003 209 215
R.J. Ragusa, C.K. Chow, and J.D. Porter Oxidative stress as a potential pathogenic mechanism in an animal model of Duchenne muscular dystrophy Neuromuscul. Disord 7 1997 379 386
M.C. Rodriguez, and M.A. Tarnopolsky Patients with dystrophinopathy show evidence of increased oxidative stress Free Radic. Biol. Med. 34 2003 1217 1220
Y. Nakae, P.J. Stoward, T. Kashiyama, M. Shono, A. Akagi, T. Matsuzaki, and I. Nonaka Early onset of lipofuscin accumulation in dystrophin-deficient skeletal muscles of DMD patients and mdx mice J. Mol. Histol. 35 2004 489 499
M.H. Disatnik, J. Dhawan, Y. Yu, M.F. Beal, M.M. Whirl, A.A. Franco, and T.A. Rando Evidence of oxidative stress in mdx mouse muscle: studies of the pre-necrotic state J. Neurol. Sci. 161 1998 77 84
T.A. Rando Oxidative stress and the pathogenesis of muscular dystrophies Am. J. Phys. Med. Rehabil 81 2002 S175 186
O.M. Dorchies, S. Wagner, O. Vuadens, K. Waldhauser, T.M. Buetler, P. Kucera, and U.T. Ruegg Green tea extract and its major polyphenol (-)-epigallocatechin gallate improve muscle function in a mouse model for Duchenne muscular dystrophy Am. J. Physiol. Cell Physiol 290 2006 C616 C625
T.M. Buetler, M. Renard, E.A. Offord, H. Schneider, and U.T. Ruegg Green tea extract decreases muscle necrosis in mdx mice and protects against reactive oxygen species Am. J. Clin. Nutr. 75 2002 749 753
O.M. Dorchies, S. Wagner, T.M. Buetler, and U.T. Ruegg Protection of dystrophic muscle cells with polyphenols from green tea correlates with improved glutathione balance and increased expression of 67LR, a receptor for (-)-epigallocatechin gallate Biofactors 35 2009 279 294
Y. Nakae, K. Hirasaka, J. Goto, T. Nikawa, M. Shono, M. Yoshida, and P.J. Stoward Subcutaneous injection, from birth, of epigallocatechin-3-gallate, a component of green tea, limits the onset of muscular dystrophy in mdx mice: a quantitative histological, immunohistochemical and electrophysiological study Histochem. Cell Biol 129 2008 489 501
S. Messina, A. Bitto, M. Aguennouz, L. Minutoli, M.C. Monici, D. Altavilla, F. Squadrito, and G. Vita Nuclear factor kappa-B blockade reduces skeletal muscle degeneration and enhances muscle function in Mdx mice Exp. Neurol. 198 2006 234 241
R. Burdi, J.F. Rolland, B. Fraysse, K. Litvinova, A. Cozzoli, V. Giannuzzi, A. Liantonio, G.M. Camerino, V. Sblendorio, R.F. Capogrosso, B. Palmieri, F. Andreetta, P. Confalonieri, L. De Benedictis, M. Montagnani, and A. De Luca Multiple pathological events in exercised dystrophic mdx mice are targeted by pentoxifylline: outcome of a large array of in vivo and ex vivo tests J. Appl. Physiol. 106 2009 1311 1324
G.M. Buyse, G. Van der Mieren, M. Erb, J. D'Hooge, P. Herijgers, E. Verbeken, A. Jara, A. Van Den Bergh, L. Mertens, I. Courdier-Fruh, P. Barzaghi, and T. Meier Long-term blinded placebo-controlled study of SNT-MC17/idebenone in the dystrophin deficient mdx mouse: cardiac protection and improved exercise performance Eur. Heart J. 30 2009 116 124
H.G. Radley, A. De Luca, G.S. Lynch, and M.D. Grounds Duchenne muscular dystrophy: focus on pharmaceutical and nutritional interventions Int. J. Biochem. Cell Biol. 39 2007 469 477
Y. Hibaoui, J. Reutenauer-Patte, O. Patthey-Vuadens, U.T. Ruegg, and O.M. Dorchies Melatonin improves muscle function of the dystrophic mdx5Cv mouse, a model for Duchenne muscular dystrophy J. Pineal Res. 51 2011 163 171
